Table 1.
Control (n = 8) | C+D (n = 8) | Dantrolene+C+D (n = 7) | Ivabradine+C+D (n = 8) | ANOVA P value |
|
---|---|---|---|---|---|
AWTd (mm) | 1.19 ± 0.08 | 1.18 ± 0.06 | 1.19 ± 0.05 | 1.19 ± 0.07 | >.05 |
AWTs (mm) | 2.17 ± 0.13 | 2.16 ± 0.12 | 2.18 ± 0.11 | 2.17 ± 0.14 | >.05 |
LVIDd (mm) | 7.18 ± 0.58 | 7.12 ± 0.47 | 7.07 ± 0.20 | 7.31 ± 0.79 | >.05 |
LVIDs (mm) | 4.07 ± 0.65 | 4.00 ± 0.44 | 3.92 ± 0.41 | 4.20 ± 0.86 | >.05 |
PWTd (mm) | 1.23 ± 0.07 | 1.24 ± 0.06 | 1.22 ± 0.07 | 1.31 ± 0.09 | >.05 |
PWTs (mm) | 2.16 ± 0.13 | 2.19 ± 0.11 | 2.18 ± 0.15 | 2.18 ± 0.14 | >.05 |
FS (%) | 43.6 ± 6.8 | 43.7 ± 5.4 | 44.5 ± 6.3 | 42.8 ± 6.0 | >.05 |
Values are mean ± SD.
ANOVA = analysis of variance; AWTd = left ventricular anterior wall thickness in diastole; AWTs = left ventricular anterior wall thickness in systole; C+D = caffeine + dobutamine; FS = left ventricular fractional shortening; LVIDd = left ventricular diameter in diastole; LVIDs = left ventricular diameter in systole; PWTd = left ventricular posterior wall thickness in diastole; PWTs = left ventricular posterior wall thickness in systole.